HomeHealth Sciences Journalvol. 11 no. 2 (2022)

Persistent trophoblastic neoplasia in the broad ligament, a case report

Ava Katrina B. Pacleb | Rosalie E. Junio | Lilli May T. Cole

 

Abstract:

Gestational trophoblastic neoplasia (GTN), a malignancy arising from trophoblastic tissue of pregnancy, is an aggressive disease process with a high probability of metastasis if left untreated. This is a case report on metastatic invasive mole arising from a molar pregnancy. Four months after suction curettage, a mass was noted in the left broad ligament on exploratory laparotomy with intact uterine serosa. Clinical presentation, biochemical, and radiological parameters led to a diagnosis of persistent trophoblastic disease. Histopathological findings also confirmed the diagnosis. Prompt chemotherapy was given after removal of the left intraligamentary mass, and subsequent response to treatment was documented. We report a case demonstrating a different clinical presentation of invasive mole and its potential to metastasize to the broad ligament without uterine perforation or direct extension.



References:

  1. Goff B, Dizon D, Chakrabarti A, Vora S. Gestational trophoblastic neoplasia: Epidemiology, clinical features, diagnosis, staging, and risk stratification. In: UpToDate Anywhere, Post TW (Ed) Uptodate, Berkowitz R, Horowitz N. Accessed on July 19, 2020.
  2. Shih IeM. Gestational trophoblastic neoplasia--pathogenesis and potential therapeutic targets. Lancet Oncol [Internet]. 2007 Jul; 8(7): 642-50. doi: 10.1016/S1470-2045(07)70204-8
  3. Shen Y, Wan X, Xie X. A metastatic invasive mole arising from iatrogenic uterus perforation. BMC Cancer [internet]. 2017 Dec 20; 17(1): 876. doi: 10.1186/s12885-017-3904-2
  4. Ngan H, Seckl M, Berkowitz R, et al. FIGO Cancer Report 2018: Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynecol Cancer [Internet]. 2018 Oct; 143 Suppl 2: 79-85. doi: 10.1002/ijgo.12615
  5. Niemann I, Vejerslev L, Froding L, et al. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling. Dan Med J [Internet]. 2015 Nov; 62(11): A5082. PMID: 26522484.
  6. Chhabra S, Qureshi A. Gestational trophoblastic neoplasms with special reference to invasive mole. J Obstet Gynecol India. 2007; 57 (2): 124-7.
  7. Amnimoghaddam S, Maghsoudnia A. Unusual presentation of invasive mole: A case report. J Reprod Infertil [Internet]. 2017 Jan-Mar; 18(1): 205-9. PMID: 28377901.
  8. Shen Y, Wan X, Xie X. A metastatic invasive mole arising from iatrogenic uterus perforation. BMC Cancer [Internet]. 2017 Dec 20; 17(1): 876. doi: 10.1186/s12885-017-3904-2
  9. Moser G, Windsperger K, Pollheimer J, de Sousa Lopes S, Heppertz B Human trophoblast invasion: New and unexpected routs and functions. Histochem Cell Biol [Internet]. 2018 Oct; 150(4): 361-70. doi: 10.1007/s00418-018-1699-0
  10. Wo n g S, H y n e s R Ly p h m a t i c o r h e m a t o ge n o u s dissemination: How does a metastatic tumor cell decide? Cell Cycle. 2006 Apr; 5(8): 812-7. doi: 10.4161/cc.5.8.2646
  11. Kleppe M, Kraima A, Kruitwagen R, Gorp T. Understanding lymphatic drainage pathways of the ovaries to predict sites for sentinel nodes in ovarian cancer. Int J Gynecol Cancer [Internet]. 2015 Oct; 25(8): 1405-14. doi: 10.1097/IGC.0000000000000514
  12. Abe H, Al-zi’abi MO, Sekizawa F, Acosta TJ, Skarzynski DJ, Okuda K. Lymphatic involvement in the disappearance of steroidogenic cells from the corpus luteum during luteolysis. PLoS One [Internet]. 2014 Feb 20; 9(2): e88953. doi: 10.1371/journal.pone.0088953
  13. Garcia M, Lin L, Fushida K, Francisco R, Zugaib M. Pregnancy outcomes after chemotherapy for trophoblastic neoplasia. Rev Assoc Med Bras (1992) [Internet]. 2016 Dec; 62(9): 837-42. doi: 10.1590/1806-9282.62.09.837